Search

everythinglearnresearchcommunity

for

Search:↓

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Ch55 may help reduce skin scarring and fibrosis.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

SARMs show promise but need more evidence to prove they're better than traditional androgens.